German Corneal Cross Linking Register

Suphi Taneri

Status: Active, not recruiting

Conditions: Keratoconus

Treatments: Procedure: CCL (Corneal Cross Linking)

Study type: Observational

Funder types: Other

Identifiers

NCT00560651

CCL

Details and patient eligibility

About

Corneal Cross Linking is new treatment modality for patients with keratoconus. A keratoconus is characterized by progressive bulging and thinning of the eye's cornea. Keratoconus is a potentially severely sight impairing condition that may necessitate corneal transplantation in the progressive state.

Corneal Cross Linking is designed to

• increase the cornea's mechanical stability
• to stop progression of bulging and thinning of the cornea
• to prevent the need for corneal transplantation

Corneal Cross Linking is performed by

1. Applying Riboflavin (Vitamin B2) eye drops every 2 minutes for 30 minutes to the cornea
2. Illuminating the cornea with UV-light

This register of Corneal Cross Linking procedures performed in Germany serves to

• gather long-term results
• detect rare complications and side-effects
• evaluate the efficacy in a large number of patients

Enrollment: 7,500 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with keratokonus and treated with corneal cross Linking in Germany

Exclusion criteria

• Non-ectatic conditions

Trial design

7,500 participants in 1 patient group

1

Description:

Cross linked eyes

Treatment:

Procedure: CCL (Corneal Cross Linking)